Top Markets
#1 Pleasing Gold Pleasing Gold +1,543.14%
#2 PulseChain PulseChain +57.52%
#3 Ontology Gas Ontology Gas +36.19%
#4 Merlin's Seal BTC Merlin's Seal BTC +31.77%
#5 BOOK OF MEME BOOK OF MEME +30.30%
#6 Collect on Fanable Collect on Fanable +24.02%
#7 Neiro Neiro +20.95%
#8 Unit Pump Unit Pump +20.03%
#9 Nockchain Nockchain +19.80%
#10 RSK Infrastructure Framework RSK Infrastructure Framework +19.17%
Coin of the day
Pleasing Gold Pleasing Gold
설정
언어
한국어
통화
USD
테마
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
주식 순위 #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
주가
$0.12164306
마지막 동기화: 2024-11-11
시가총액
$38.53M
변동 (1일)
-4.14%
변동 (1년)
0.00%
국가
AU
거래 PharmAust Limited (PAA)

카테고리

Healthcare
PharmAust Limited (PAA)의 P/S 비율
August 2026 기준 P/S 비율 TTM: 0.00
PharmAust Limited의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0.00입니다. 2024년 말 기준 P/S 비율은 0.00였습니다.
PharmAust Limited의 P/S 비율 기록 (2001 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 -100.00%
2023 8.53 29.96%
2022 6.56 -51.13%
2021 13.42 -6.50%
2020 14.36 611.37%
2019 2.02 20.63%
2018 1.67 -19.73%
2017 2.08 -15.55%
2016 2.47 -36.92%
2015 3.91 -40.73%
2014 6.60 108.20%
2013 3.17 87.09%
2012 1.70 -67.92%
2011 5.28 -58.41%
2010 12.70 360.27%
2009 2.76 66.79%
2008 1.65 66.92%
2007 0.99 -42.02%
2006 1.71 -41.66%
2005 2.93 -80.04%
2004 14.68 -38.19%
2003 23.75 159.55%
2002 9.15 0.00%
2001 0.00 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH